Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • EGFR
    (3)
  • Drug Metabolite
    (2)
  • Cytochromes P450
    (1)
  • Others
    (2)
Filter
Search Result
Results for "

alflutinib

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    6
    TargetMol | Inhibitors_Agonists
Alflutinib
AST2818, Firmonertinib
T222541869057-83-9
Alflutinib (Firmonertinib) is an inhibitor of EGFR, and its targets including EGFR activating mutations and T790M, thus leading to tumor growth inhibition.
  • Inquiry Price
Size
QTY
Alflutinib mesylate
AST2818 mesylate
T71752130958-55-1
Alflutinib mesylate (AST2818 mesylate) ,is an irreversible tyrosine kinase inhibitor that selectively inhibits EGFR mutations, especially T790M.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
AST5902 (trimesylate)
T2051872929417-90-1
AST5902 trimesylate is the primary metabolite of Alflutinib (AST2818) both in vivo and in vitro. It exhibits antitumor activity. Alflutinib functions as an EGFR inhibitor.
  • Inquiry Price
Size
QTY
AST5902 trimesylate
T35361
AST5902 trimesylate is a useful organic compound for research related to life sciences and the catalog number is T35361.
  • Inquiry Price
Size
QTY
AST5902
T89452412155-74-7
AST5902, the active metabolite of Alflutinib, is a compound critical in [its mechanism of action].
  • Inquiry Price
Size
QTY
AST5902 mesylate(2412155-74-7 free base)
T8945L2412155-75-8
AST5902 mesylate is principal metabolite of Alflutinib in vivo. AST5902 mesylate exerts antineoplastic activity.
  • Inquiry Price
Size
QTY